- Home
- INM vs PALI Comparison
INM vs PALI Comparison
Compare INM & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- PALI
- Stock Information
- Founded
- INM 1981
- PALI 1996
- Country
- INM Canada
- PALI United States
- Employees
- INM N/A
- PALI N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INM Health Care
- PALI Health Care
- Exchange
- INM Nasdaq
- PALI Nasdaq
- Market Cap
- INM 3.2M
- PALI 3.2M
- IPO Year
- INM N/A
- PALI N/A
- Fundamental
- Price
- INM $2.95
- PALI $0.69
- Analyst Decision
- INM
- PALI Strong Buy
- Analyst Count
- INM 0
- PALI 2
- Target Price
- INM N/A
- PALI $12.00
- AVG Volume (30 Days)
- INM 214.0K
- PALI 377.3K
- Earning Date
- INM 05-27-2025
- PALI 05-12-2025
- Dividend Yield
- INM N/A
- PALI N/A
- EPS Growth
- INM N/A
- PALI N/A
- EPS
- INM N/A
- PALI N/A
- Revenue
- INM $4,920,990.00
- PALI N/A
- Revenue This Year
- INM N/A
- PALI N/A
- Revenue Next Year
- INM N/A
- PALI N/A
- P/E Ratio
- INM N/A
- PALI N/A
- Revenue Growth
- INM N/A
- PALI N/A
- 52 Week Low
- INM $1.72
- PALI $0.60
- 52 Week High
- INM $15.70
- PALI $8.57
- Technical
- Relative Strength Index (RSI)
- INM 53.78
- PALI 40.57
- Support Level
- INM $2.08
- PALI $0.62
- Resistance Level
- INM $4.00
- PALI $1.05
- Average True Range (ATR)
- INM 0.35
- PALI 0.09
- MACD
- INM 0.01
- PALI -0.01
- Stochastic Oscillator
- INM 45.31
- PALI 15.53
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.